In this study, we analyzed the safety and efficacy of PD - 1 inhibitors in the treatment of advanced cancer in HIV/AIDS patients in order to provide clinical data supporting immunotherapy in HIV/AIDS patients with cancer. Here, RPL17 is linked to AIDS.